BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28611377)

  • 1. Atrial fibrillation as a prognostic indicator of myocardial infarction and cardiovascular death: a systematic review and meta-analysis.
    He W; Chu Y
    Sci Rep; 2017 Jun; 7(1):3360. PubMed ID: 28611377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
    Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
    Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
    Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates and risk of cardiovascular events: a meta-analysis.
    Kim DH; Rogers JR; Fulchino LA; Kim CA; Solomon DH; Kim SC
    PLoS One; 2015; 10(4):e0122646. PubMed ID: 25884398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis.
    Ruddox V; Sandven I; Munkhaugen J; Skattebu J; Edvardsen T; Otterstad JE
    Eur J Prev Cardiol; 2017 Sep; 24(14):1555-1566. PubMed ID: 28617620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intervention Associated Acute Kidney Injury and Long-Term Cardiovascular Outcomes.
    Saratzis A; Harrison S; Barratt J; Sayers RD; Sarafidis PA; Bown MJ
    Am J Nephrol; 2015; 42(4):285-94. PubMed ID: 26495853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial.
    Proietti M; Raparelli V; Olshansky B; Lip GY
    Clin Res Cardiol; 2016 May; 105(5):412-20. PubMed ID: 26525391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation is associated with an increased risk of myocardial infarction: Insights from a meta-analysis.
    Guo XY; Li N; Du X; Bai R; Yu RH; Long DY; Tang RB; Sang CH; Jiang CX; Ning M; Li SN; Liu N; Dong JZ; Ma CS
    Atherosclerosis; 2016 Nov; 254():1-7. PubMed ID: 27673698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.
    Chan YH; Yiu KH; Lau KK; Yiu YF; Li SW; Lam TH; Lau CP; Siu CW; Tse HF
    Atherosclerosis; 2014 Dec; 237(2):504-13. PubMed ID: 25463082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation is associated with sudden cardiac death: a systematic review and meta-analysis.
    Rattanawong P; Upala S; Riangwiwat T; Jaruvongvanich V; Sanguankeo A; Vutthikraivit W; Chung EH
    J Interv Card Electrophysiol; 2018 Mar; 51(2):91-104. PubMed ID: 29332241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis.
    Jabre P; Roger VL; Murad MH; Chamberlain AM; Prokop L; Adnet F; Jouven X
    Circulation; 2011 Apr; 123(15):1587-93. PubMed ID: 21464054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-aged patients with atrial fibrillation: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Vasiljevic ZM; Vujisic-Tesic BD; Marinkovic JM; Polovina MM; Stepanovic JM; Stankovic GR; Ostojic MC; Lip GYH
    Chest; 2011 Oct; 140(4):902-910. PubMed ID: 21436252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.
    Goto S; Bhatt DL; Röther J; Alberts M; Hill MD; Ikeda Y; Uchiyama S; D'Agostino R; Ohman EM; Liau CS; Hirsch AT; Mas JL; Wilson PW; Corbalán R; Aichner F; Steg PG;
    Am Heart J; 2008 Nov; 156(5):855-63, 863.e2. PubMed ID: 19061698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation.
    Pignatelli P; Pastori D; Carnevale R; Farcomeni A; Cangemi R; Nocella C; Bartimoccia S; Vicario T; Saliola M; Lip GY; Violi F
    Thromb Haemost; 2015 Mar; 113(3):617-24. PubMed ID: 25392853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.
    Pastori D; Pignatelli P; Angelico F; Farcomeni A; Del Ben M; Vicario T; Bucci T; Raparelli V; Cangemi R; Tanzilli G; Lip GYH; Violi F
    Chest; 2015 Jun; 147(6):1644-1650. PubMed ID: 25429521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and prognostic significance of silent atrial fibrillation in acute myocardial infarction.
    Stamboul K; Zeller M; Fauchier L; Gudjoncik A; Buffet P; Garnier F; Guenancia C; Lorgis L; Beer JC; Touzery C; Cottin Y
    Int J Cardiol; 2014 Jul; 174(3):611-7. PubMed ID: 24801093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Morbidity and Mortality Related to Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Bisaccia G; Ricci F; Khanji MY; Sorella A; Melchiorre E; Iannetti G; Galanti K; Mantini C; Pizzi AD; Tana C; Renda G; Fedorowski A; De Caterina R; Gallina S
    Curr Probl Cardiol; 2023 Jun; 48(6):101643. PubMed ID: 36773944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation and death after myocardial infarction: a community study.
    Jabre P; Jouven X; Adnet F; Thabut G; Bielinski SJ; Weston SA; Roger VL
    Circulation; 2011 May; 123(19):2094-100. PubMed ID: 21536994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular outcomes in breast cancer survivors: a systematic review and meta-analysis.
    Galimzhanov A; Istanbuly S; Tun HN; Ozbay B; Alasnag M; Ky B; Lyon AR; Kayikcioglu M; Tenekecioglu E; Panagioti M; Kontopantelis E; Abdel-Qadir H; Mamas MA
    Eur J Prev Cardiol; 2023 Dec; 30(18):2018-2031. PubMed ID: 37499186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence and prognostic significance of new-onset atrial fibrillation in patients with acute myocardial infarction and left ventricular systolic dysfunction: a CARISMA substudy.
    Jons C; Jacobsen UG; Joergensen RM; Olsen NT; Dixen U; Johannessen A; Huikuri H; Messier M; McNitt S; Thomsen PE;
    Heart Rhythm; 2011 Mar; 8(3):342-8. PubMed ID: 21093611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.